![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 21, 15621-15628, May 26, 2000
,
,
From Sanofi-Synthélabo,
34184 Montpellier Cedex 04, France
The function of the peripheral cannabinoid
receptor (CB2), which is mainly expressed on hematopoietic cells,
remains an enigma. In an attempt to decipher its role, we used
AffymetrixTM DNA chips to investigate the gene
expression profile of the promyelocytic cells HL-60 transfected with
the CB2 receptor and activated with the cannabinoid agonist CP 55,940. Agonist exposure of these cells led to an activation of a
mitogen-activated protein kinase cascade and a receptor
desensitization, indicating a functional coupling of the transfected
receptors. At the genomic level, activation of the CB2 receptors
induced an up-regulation of nine genes involved in cytokine synthesis,
regulation of transcription, and cell differentiation. A majority of
them are under the control of the transcription factor NF-
B, whose
nuclear translocation was demonstrated. Many features of the
transcriptional events, reported here for the first time, appeared to
be related to an activation of a cell differentiation program,
suggesting that CB2 receptors could play a role in the initialization
of cell maturation. Moreover, we showed that CB2-activated wild-type
HL-60 cells developed properties usually found in host defense effector
cells such as an enhanced release of chemotactic cytokines and an
increased motility, characteristic of more mature cells of the
granulocytic-monocytic lineage.
These authors contributed equally to this work.
§
To whom correspondence should be addressed:
Sanofi-Synthélabo, 371 rue du Prof. Joseph Blayac,
34184 Montpellier Cedex 04, France. Tel.: 33-467-10-62-90; Fax:
33-467-10-60-00; E-mail: pierre.casellas@ sanofi-synthelabo.com.
This article has been cited by other articles:
![]() |
D. McHugh, C. Tanner, R. Mechoulam, R. G. Pertwee, and R. A. Ross Inhibition of Human Neutrophil Chemotaxis by Endogenous Cannabinoids and Phytocannabinoids: Evidence for a Site Distinct from CB1 and CB2 Mol. Pharmacol., February 1, 2008; 73(2): 441 - 450. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Roosterman, T. Goerge, S. W. Schneider, N. W. Bunnett, and M. Steinhoff Neuronal control of skin function: the skin as a neuroimmunoendocrine organ. Physiol Rev, October 1, 2006; 86(4): 1309 - 1379. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Gonsiorek, D. Hesk, S.-C. Chen, D. Kinsley, J. S. Fine, J. V. Jackson, L. A. Bober, G. Deno, H. Bian, J. Fossetta, et al. Characterization of Peripheral Human Cannabinoid Receptor (hCB2) Expression and Pharmacology Using a Novel Radioligand, [35S]Sch225336 J. Biol. Chem., September 22, 2006; 281(38): 28143 - 28151. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kurihara, Y. Tohyama, S. Matsusaka, H. Naruse, E. Kinoshita, T. Tsujioka, Y. Katsumata, and H. Yamamura Effects of Peripheral Cannabinoid Receptor Ligands on Motility and Polarization in Neutrophil-like HL60 Cells and Human Neutrophils J. Biol. Chem., May 5, 2006; 281(18): 12908 - 12918. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Benito, W.-K. Kim, I. Chavarria, C. J. Hillard, K. Mackie, R. M. Tolon, K. Williams, and J. Romero A Glial Endogenous Cannabinoid System Is Upregulated in the Brains of Macaques with Simian Immunodeficiency Virus-Induced Encephalitis J. Neurosci., March 9, 2005; 25(10): 2530 - 2536. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Rockwell and N. E. Kaminski A Cyclooxygenase Metabolite of Anandamide Causes Inhibition of Interleukin-2 Secretion in Murine Splenocytes J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 683 - 690. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. Klein, C. Newton, K. Larsen, L. Lu, I. Perkins, L. Nong, and H. Friedman The cannabinoid system and immune modulation J. Leukoc. Biol., October 1, 2003; 74(4): 486 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Franklin, S. Parmentier-Batteur, L. Walter, D. A. Greenberg, and N. Stella Palmitoylethanolamide Increases after Focal Cerebral Ischemia and Potentiates Microglial Cell Motility J. Neurosci., August 27, 2003; 23(21): 7767 - 7775. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-T. Samson, A. Small-Howard, L. M. N. Shimoda, M. Koblan-Huberson, A. J. Stokes, and H. Turner Differential Roles of CB1 and CB2 Cannabinoid Receptors in Mast Cells J. Immunol., May 15, 2003; 170(10): 4953 - 4962. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Friedman, C. Newton, and T. W. Klein Microbial Infections, Immunomodulation, and Drugs of Abuse Clin. Microbiol. Rev., April 1, 2003; 16(2): 209 - 219. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Walter, A. Franklin, A. Witting, C. Wade, Y. Xie, G. Kunos, K. Mackie, and N. Stella Nonpsychotropic Cannabinoid Receptors Regulate Microglial Cell Migration J. Neurosci., February 15, 2003; 23(4): 1398 - 1405. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Parmentier-Batteur, K. Jin, L. Xie, X. O. Mao, and D. A. Greenberg DNA Microarray Analysis of Cannabinoid Signaling in Mouse Brain in Vivo Mol. Pharmacol., October 1, 2002; 62(4): 828 - 835. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Johnston, W. Jiang, T. Chu, and B. Levine Identification of Genes Involved in the Host Response to Neurovirulent Alphavirus Infection J. Virol., November 1, 2001; 75(21): 10431 - 10445. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |